Psychiatry Generic Medicines
Estimated value
—
Awarded value
—
Suppliers
54
Lots
7
Published
03 Sept 2021
Description
This Framework Agreement is for the supply of Psychiatry Generic Medicines to health boards across NHS Scotland. The Goods have been split into seven (7) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Scope
- Reference
- NP30921
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for further periods up to a total period of twelve (12) months upon giving not less than three (3) months written notice to expire no later than the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- ScotlandUK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 7 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 7 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 3 | Sodium Valproate tablets, modified release tablets, capsules and granules, injection, solution, liquid and syrup | £465k | cancelled |
| 2 | Lamotrigine tablets and dispersible tablets | £211k | cancelled |
| 4 | Levodopa/Carbidopa/Entacapone film coated tablets | £3k | cancelled |
| 5 | Phenytoin Sodium Capsules, tablets and ampoules | £107k | cancelled |
| 7 | All other Psychiatry Generic Medicines | £13.4m | cancelled |